Drawing for TEARSCIENCE

USPTO serial 77508554

TEARSCIENCE

Reviewed by CopyMark Law Group

Reg. 4019792Status 800Registered
Filing date
Status date
Registration date
Aug 30, 2011
Examiner
SOBRAL, CHRISTINA
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with TEARSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marci A. Blazer

Marci A. Blazer Johnson & JohnsonOne Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and software, and parts and accessories therefor, for use with analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Optical and photographic apparatus and instruments, and parts and accessories therefor, namely, interferometers and cameras, for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical temperature controller, and parts and accessories therefor, used primarily for temperature controller purposes, namely, for delivering and controlling heat to meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical pressure controller, and parts and accessories therefor, used primarily for controlling pressure, namely, for applying and controlling pressure to the meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical fluid transfer controller, and parts and accessories therefor, used primarily for controlling and transferring heated fluid to the eye for use in treating eye disease, namely, dry eye and meibomian gland dysfunctionACTIVEMay 31, 2010
010Medical apparatuses and devices, and parts and accessories therefor, used for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Medical device, and parts and accessories therefor, for expressing obstructions or occlusions from meibomian glands; Medical heater used primarily for medical purposes, namely, for applying heat to a patient's eye and related eye structure for treating eye diseases, namely, dry eye and meibomian gland dysfunction; Medical devices, namely, medical contact lens used primarily for medical purposes containing an electrical heating element for applying heat to meibomian glands when installed on a patient's eye for treating dry eye and meibomian gland dysfunction; medical imaging apparatuses and devices in the nature of a system comprising optical lens, camera, lamp, LED, spectrometer, used for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction sold as a unitACTIVEMay 31, 2010
016Printed [ instructional, ] educational [ and teaching ] materials in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Printed instructional, educational and teaching materials for analysis, diagnosis, treatment, and monitoring of eye disease, namely, dry eye and meibomian gland dysfunctionACTIVEMay 31, 2010
044[ Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of eye diseases and conditions; Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of dry eye and meibomian gland dysfunction; ] Providing medical information related to eye disease, namely, dry eye and meibomian gland dysfunction, for educational purposesACTIVEMay 31, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2022NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Feb 1, 2022RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 1, 202289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 31, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 23, 2021E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 30, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 11, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 11, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 6, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 22, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 22, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 22, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 14, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 14, 2016E815TEAS SECTION 8 & 15 RECEIVED—
Aug 30, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 23, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 30, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
Jul 25, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 25, 2011ALIEASSIGNED TO LIE—
Jun 29, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 28, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2011CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 3, 2011IUAFUSE AMENDMENT FILED—
Mar 3, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 8, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Sep 7, 2010EX3GSOU EXTENSION 3 GRANTED—
Sep 2, 2010EXT3SOU EXTENSION 3 FILED—
Sep 2, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 8, 2010EX2GSOU EXTENSION 2 GRANTED—
Mar 3, 2010EXT2SOU EXTENSION 2 FILED—
Mar 3, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2009EX1GSOU EXTENSION 1 GRANTED—
Sep 22, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 3, 2009EXT1SOU EXTENSION 1 FILED—
Sep 3, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 14, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 9, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 19, 2008NPUBNOTICE OF PUBLICATION—
Nov 4, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 4, 2008CNEAEXAMINERS AMENDMENT MAILED—
Nov 4, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 4, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Nov 4, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 31, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2008DOCKASSIGNED TO EXAMINER—
Jul 15, 2008AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 14, 2008ALIEASSIGNED TO LIE—
Jul 14, 2008PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 30, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance